在心脏保护中由介质干细胞衍生出来的外体:一种新的应用,以预防心肌损伤
Shaokang Yang1, Jialin Li2, Mingbo Tang2
1Department of Gastric and Colorectal Surgery, General Surgery Center, The First Hospital of Jilin University, 130021 Changchun, Jilin, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
介质细胞干细胞衍生外体 (MSC-Exos) 为预防外科手术期间心肌损伤提供了一个有前途的无细胞疗法. 这篇评论探讨了它们在调节炎症,亡和促进心脏修复方面的潜力.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 术后心肌损伤是经常出现的手术并发症.
- 目前的心脏保护方法不足以满足临床需求.
- 介质细胞干细胞衍生外体 (MSC-Exos) 是一种新的治疗方法.
研究的目的:
- 审查MSC-Exos在预防心肌梗塞/损伤方面的应用.
- 分析MSC-Exos在心脏保护中的机制.
- 评估MSC-Exos的临床治疗效果和挑战.
主要方法:
- 关于MSC-Exos在外科手术期间心肌损伤方面的综合文献审查.
- 对MSC-Exos在调节炎症,亡和自的作用的分析.
- 评估MSC-Exos对血管生成和心脏重塑的影响.
主要成果:
- MSC-Exos在减少心肌损伤方面显示出潜力.
- 机制包括抗炎作用,抑制心肌细胞亡和自.
- 促进血管新生和有利的心脏重塑是关键的好处.
结论:
- 在外科手术期间心肌损伤方面,MSC-Exos显示出显著的治疗前景.
- 需要进一步进行临床评估,以克服相关挑战.
- MSC-Exos代表了一种可行的无细胞心脏保护策略.
相关概念视频
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K